A detailed history of Fort Point Capital Partners LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Fort Point Capital Partners LLC holds 5,891 shares of ABBV stock, worth $1.06 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
5,891
Previous 5,232 12.6%
Holding current value
$1.06 Million
Previous $897,000 29.65%
% of portfolio
0.14%
Previous 0.11%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$163.84 - $199.33 $107,970 - $131,358
659 Added 12.6%
5,891 $1.16 Million
Q2 2024

Aug 14, 2024

BUY
$154.79 - $180.76 $6,501 - $7,591
42 Added 0.81%
5,232 $897,000
Q1 2024

May 14, 2024

SELL
$159.82 - $182.1 $1,598 - $1,821
-10 Reduced 0.19%
5,190 $945,000
Q4 2023

Feb 09, 2024

SELL
$137.6 - $154.97 $156,588 - $176,355
-1,138 Reduced 17.96%
5,200 $805,000
Q3 2023

Nov 08, 2023

SELL
$133.59 - $154.65 $36,202 - $41,910
-271 Reduced 4.1%
6,338 $944,000
Q2 2023

Aug 14, 2023

SELL
$132.51 - $164.9 $86,131 - $107,185
-650 Reduced 8.95%
6,609 $890,000
Q1 2023

May 11, 2023

BUY
$144.61 - $166.54 $206,213 - $237,486
1,426 Added 24.45%
7,259 $1.16 Million
Q4 2022

Feb 14, 2023

SELL
$138.31 - $165.87 $92,114 - $110,469
-666 Reduced 10.25%
5,833 $943,000
Q3 2022

Nov 09, 2022

SELL
$134.21 - $153.93 $2,818 - $3,232
-21 Reduced 0.32%
6,499 $872,000
Q2 2022

Aug 15, 2022

SELL
$137.62 - $174.96 $18,853 - $23,969
-137 Reduced 2.06%
6,520 $999,000
Q1 2022

May 13, 2022

BUY
$131.98 - $163.75 $116,538 - $144,591
883 Added 15.29%
6,657 $1.08 Million
Q4 2021

Feb 14, 2022

SELL
$107.43 - $135.93 $537 - $679
-5 Reduced 0.09%
5,774 $782,000
Q3 2021

Nov 12, 2021

BUY
$106.4 - $120.78 $249,401 - $283,108
2,344 Added 68.24%
5,779 $623,000
Q2 2021

Jul 30, 2021

BUY
$105.21 - $117.21 $10,521 - $11,721
100 Added 3.0%
3,435 $387,000
Q1 2021

May 10, 2021

BUY
$102.3 - $112.62 $818 - $900
8 Added 0.24%
3,335 $361,000
Q3 2020

Nov 10, 2020

SELL
$85.91 - $100.83 $5.93 Million - $6.96 Million
-69,007 Reduced 95.4%
3,327 $291,000
Q2 2020

Aug 13, 2020

BUY
$73.37 - $98.18 $12,986 - $17,377
177 Added 0.25%
72,334 $7.1 Million
Q1 2020

May 14, 2020

SELL
$64.5 - $97.79 $506,325 - $767,651
-7,850 Reduced 9.81%
72,157 $5.5 Million
Q4 2019

Feb 03, 2020

BUY
$72.13 - $90.25 $72 - $90
1 Added 0.0%
80,007 $7.08 Million
Q3 2019

Nov 14, 2019

BUY
$62.98 - $75.72 $49,817 - $59,894
791 Added 1.0%
80,006 $6.06 Million
Q2 2019

Aug 09, 2019

SELL
$65.7 - $83.98 $2.42 Million - $3.09 Million
-36,786 Reduced 31.71%
79,215 $5.76 Million
Q1 2019

May 13, 2019

SELL
$77.14 - $90.79 $45,126 - $53,112
-585 Reduced 0.5%
116,001 $9.35 Million
Q4 2018

Feb 11, 2019

SELL
$77.85 - $96.01 $12,845 - $15,841
-165 Reduced 0.14%
116,586 $10.7 Million
Q3 2018

Nov 14, 2018

BUY
$88.91 - $98.84 $800 - $889
9 Added 0.01%
116,751 $11 Million
Q2 2018

Aug 13, 2018

BUY
$89.78 - $106.23 $41,119 - $48,653
458 Added 0.39%
116,742 $10.8 Million
Q1 2018

May 15, 2018

SELL
$92.01 - $123.21 $14,721 - $19,713
-160 Reduced 0.14%
116,284 $11 Million
Q4 2017

Feb 14, 2018

BUY
$89.56 - $98.21 $91,619 - $100,468
1,023 Added 0.89%
116,444 $11.3 Million
Q3 2017

Nov 14, 2017

BUY
$69.85 - $89.22 $8.06 Million - $10.3 Million
115,421
115,421 $10.3 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Fort Point Capital Partners LLC Portfolio

Follow Fort Point Capital Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fort Point Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fort Point Capital Partners LLC with notifications on news.